Evidence map›Paper›PMID 36503694›Full record

ArticleThe British journal of psychiatry : the journal of mental science2023

Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.

Mohammad Ahangari, Daniel Bustamante, Robert Kirkpatrick, Tan-Hoang Nguyen, Brian C Verrelli, Ayman Fanous, Kenneth S Kendler, Bradley T Webb, Silviu-Alin Bacanu, Brien P Riley

Open access · hybridAbstract read
In one paragraph

Article in The British journal of psychiatry : the journal of mental science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The impact of collider bias on genetic prediction in psychotic disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mohammad AhangariVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Integrative Life Sciences PhD Program, Virginia Commonwealth University, USA.ORCID 0000-0002-6585-5523
Daniel BustamanteVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Integrative Life Sciences PhD Program, Virginia Commonwealth University, USA.
Robert KirkpatrickVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Department of Psychiatry, Virginia Commonwealth University, USA.
Tan-Hoang NguyenVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Department of Psychiatry, Virginia Commonwealth University, USA.
Brian C VerrelliCenter for Biological Data Science, Virginia Commonwealth University, USA.
Ayman FanousDepartment of Psychiatry, University of Arizona, USA.
Kenneth S KendlerVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; Department of Psychiatry, Virginia Commonwealth University, USA; and Department of Human and Molecular Genetics, Virginia Commonwealth University, USA.
Bradley T WebbGenOmics, Bioinformatics, and Translational Research Center, Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, USA.ORCID 0000-0002-0576-5366
Silviu-Alin BacanuVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Department of Psychiatry, Virginia Commonwealth University, USA.
Brien P RileyVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; Department of Psychiatry, Virginia Commonwealth University, USA; and Department of Human and Molecular Genetics, Virginia Commonwealth University, USA.
Virginia Commonwealth University · USRTI International · USUniversity of Arizona · US

Funding

MULTICENTER GENETIC STUDIES OF SCHIZOPHRENIAR01MH062276 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI LEVINSON, DOUGLAS FREDERICK · 2000 to 2008
$3.2M
Whole Genome Sequencing in Irish Multiplex Schizophrenia FamiliesR01MH114593 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI RILEY, BRIEN P · 2017 to 2021
$2.1M
Multicenter Genetic Studies of SchizophreniaR01MH068881 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI RILEY, BRIEN P · 2004 to 2007
$431k
NIMH NIH HHS R01 MH062276NIMH NIH HHS R01 MH068881NIMH NIH HHS R01 MH114593
6 · The paper itself

Abstract

backgroundPsychotic disorders and schizotypal traits aggregate in the relatives of probands with schizophrenia. It is currently unclear how variability in symptom dimensions in schizophrenia probands and their relatives is associated with polygenic liability to psychiatric disorders.

aimsTo investigate whether polygenic risk scores (PRSs) can predict symptom dimensions in members of multiplex families with schizophrenia.

methodThe largest genome-wide data-sets for schizophrenia, bipolar disorder and major depressive disorder were used to construct PRSs in 861 participants from the Irish Study of High-Density Multiplex Schizophrenia Families. Symptom dimensions were derived using the Operational Criteria Checklist for Psychotic Disorders in participants with a history of a psychotic episode, and the Structured Interview for Schizotypy in participants without a history of a psychotic episode. Mixed-effects linear regression models were used to assess the relationship between PRS and symptom dimensions across the psychosis spectrum.

resultsSchizophrenia PRS is significantly associated with the negative/disorganised symptom dimension in participants with a history of a psychotic episode (

conclusionsPolygenic liability to schizophrenia is associated with higher negative/disorganised symptoms in participants with a history of a psychotic episode and negative symptoms in participants without a history of a psychotic episode in multiplex families with schizophrenia. These results provide genetic evidence in support of the spectrum model of schizophrenia, and support the view that negative and disorganised symptoms may have greater genetic basis than positive symptoms, making them better indices of familial liability to schizophrenia.

Indexed as

Major Depressive DisorderPsychotic DisordersSchizophreniaSchizotypal Personality DisorderHumansRisk Factorsgeneticsnegative symptomspsychotic disordersSchizophreniaschizotypy

Identifiers

PMID36503694
PMCPMC10258219
OpenAlexW4311204974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.